← All organizations

Syndesi

For profit

Also known as: Syndesi Therapeutics

Highest phase reached

Phase 1

First clinical trial

Mar 14, 2019

Last known activity

Sep 23, 2021

Acquired by AbbVie on Mar 7, 2022

Timeline

2010s

  1. Jun 1, 2017

    Syndesi— Founded

2020s

  1. Mar 7, 2022

    AbbVie— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 1 (1 own, 0 via acquisition)

Recent trials (4)

Details

Founded
Brussels, BE Jun 1, 2017
Last known activity
Sep 23, 2021